Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

On Tuesday, September 16, stock prices moved a little lower as investors decided to take some profits ahead of the Federal Reserve interest rate decision. The S&P 500 fell by 0.13% after reaching a ...

Perhaps the single biggest question on the minds of US equity investors today is to what extent the AI trade resembles previous market bubble episodes, with the late ‘90s Internet/Telecom bubble the ...

Nasdaq reports record IPOs and capital raise in 2025's first half, maintaining leadership in U.S. listings and market value. Nasdaq announced strong performance in the first half of 2025, marking the ...